(Health Korea News / Lee Chang-yong) ‘Pharmaceutical 24 Hours’ is a corner that shows you at a glance the short news related to pharmaceuticals and biotechnology that you might easily miss. It may seem like trivial news, but it can be valuable information to someone, so we summarize only the facts and show you in an easy-to-understand manner.
◆ Anguk Cultural Foundation, ‘AG New Artist Award’ Contest 2023 Grand Prize Winner Invitational Exhibition
The Anguk Cultural Foundation will be holding the ‘Agua Viva – Inaha’ exhibition as an invitational exhibition for the winner of the 2023 ‘AG New Artist Award’ contest at the AG Gallery until the 30th.
‘Agua Viva’ is a word meaning ‘living water’ or ‘jellyfish’ taken from Clarice Lispector’s book. Inaha, the 2023 Grand Prize winner, wants to show a free world with ‘no framework’, that is, a world without a structure that forces a specific form, through ‘Agua Viva’.
AG Gallery, sponsored by Anguk Pharmaceutical and operated by Anguk Cultural Foundation, selects six artists every year through the AG New Artist Award Contest to discover and support new artists. Selected artists are members and can receive support for ongoing exhibitions and purchase of works.
◆ Pharmaceutical and Biotechnology Association, National Assembly and Pharmaceutical and Biotechnology AI Transformation Seek
As the government selects the biohealth industry as a next-generation key industry and plans to focus investment on new drugs and digital therapeutics utilizing AI, experts from the National Assembly, government, and academia and industry are coming together to discuss the task of AI transformation.
The Korea Pharmaceutical and Bio-Pharmaceutical Association and the National Assembly Research Group, AI and Our Future, will hold a discussion on ‘AI Transformation of the Pharmaceutical and Bio-Pharmaceutical Industry’ in the 8th conference room of the National Assembly Members’ Hall on the 26th.
This discussion, which begins with an opening speech by Rep. Choi Soo-jin, Co-Chairperson of the National Assembly AI and Our Future, will explore policy directions and tasks for AI innovation in the pharmaceutical and biotech sectors, with Reps. Kim Gun and Choi Bo-yoon, Co-Chairpersons of the National Assembly AI and Our Future, and Park Chung-kwon, Research Director, joining together. Kang Jae-woo, CEO of Aizen Science, will share “Pharmaceutical and Biotech Industry Innovation Plans in the LLM Era,” and Kim Hwa-jong, Director of the K-Melody Business Unit, will present “Policy Proposals for a Pharmaceutical and Biotech AI Powerhouse.”
Copyright © Health Korea News. Unauthorized reproduction and redistribution prohibited.
Source: www.hkn24.com
